Join P95 Julius Clinical at the 19th Clinical Trials on Alzheimer’s Disease (CTAD) in Boston from November 16-19, 2026.

Meet our neuroscience experts at CTAD 2026 to discover how P95 Julius Clinical supports efficient, high-quality clinical trials across complex neurological and psychiatric conditions. Our team partners with sponsors to navigate the unique challenges of neuroscience drug development, delivering tailored strategies that accelerate timelines while maintaining scientific rigor.

Let’s Meet in Boston!

Connect with our team at CTAD 2026 to discuss how we can support your next neuroscience clinical trial.

Name(Required)